Bullbearadvisor 
Hims & Hers Health Inc. (NYSE: HIMS) is a telehealth platform founded in 2017 and headquartered in San Francisco, California. The company connects consumers with licensed healthcare professionals, offering services across various domains, including mental health, sexual health, dermatology, and primary care. Through its websites and mobile applications, Hims & Hers provides access to prescription medications, over-the-counter products, and personalized treatment plans, aiming to make healthcare more accessible and convenient. chartmill.com+10marketbeat.com+10tipranks.com+10tipranks.com+2barchart.com+2marketbeat.com+2
Over the past 52 weeks, HIMS stock has traded between a low of $11.20 and a high of $72.98. tipranks.com+3finance.yahoo.com+3markets.businessinsider.com+3
As of the latest data, the stock is trading at $45.09.chartmill.com
Analyst sentiment toward Hims & Hers Health is mixed. According to MarketWatch, the company has received an average recommendation of "Hold," with an average target price of $43.80, based on 15 analyst ratings. Similarly, ChartMill reports that 22 analysts have analyzed HIMS, with a buy consensus of 72% and a mean price target of $29.95, indicating a potential downside from the current price. chartmill.com+10investors.com+10marketbeat.com+10marketwatch.comchartmill.com+1chartmill.com+1
Subscribe to our API. See Strong Buy and Sell Signals the Day after They Occur!
